Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B P Morgan

Showing results (51-60 of 247) with videos related to

Pageof 25
Sort By:
Lancet (London, England)|September 12, 1992
Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cellsA P Weetman, N Tandon, B P Morgan
The Biochemical Journal|April 1, 1988
The preparation and characterization of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunitsA Abraha, B P Morgan, J P Luzio
Immunology|April 1, 1997
Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for functionN K Rushmere, S Tomlinson, B P Morgan
Immunology|September 1, 1999
Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46)R Mead, S J Hinchliffe, B P Morgan
Clinical and Experimental Immunology|October 1, 1990
Thyroid follicular cell function after non-lethal complement membrane attackA P Weetman, M Freeman, B P Morgan
Immunology|February 1, 1992
Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cellsN Tandon, B P Morgan, A P Weetman
The Biochemical Journal|April 15, 1990
Reversible cell damage by T-cell perforins. Calcium influx and propidium iodide uptake into K562 cells in the absence of lysisJ Jones, M B Hallett, B P Morgan
Biochemical Society Transactions|July 26, 2000
Non-lethal effects of perforin on polymorphonuclear leukocytesJ I Hopkins, J Jones, B P Morgan
Journal of Immunological Methods|June 5, 1999
Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cellsO B Spiller, C L Harris, B P Morgan
Biochemical Society Transactions|July 18, 2000
Therapeutic uses of recombinant complement receptorsB P Morgan, N K Rushmere, C L Harris
Pageof 25

Showing results (51-60 of 247) with videos related to

Sort By:
Pageof 25
Lancet (London, England)|September 12, 1992
Antithyroid drugs and release of inflammatory mediators by complement-attacked thyroid cellsA P Weetman, N Tandon, B P Morgan
The Biochemical Journal|April 1, 1988
The preparation and characterization of monoclonal antibodies to human complement component C8 and their use in purification of C8 and C8 subunitsA Abraha, B P Morgan, J P Luzio
Immunology|April 1, 1997
Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for functionN K Rushmere, S Tomlinson, B P Morgan
Immunology|September 1, 1999
Molecular cloning, expression and characterization of the rat analogue of human membrane cofactor protein (MCP/CD46)R Mead, S J Hinchliffe, B P Morgan
Clinical and Experimental Immunology|October 1, 1990
Thyroid follicular cell function after non-lethal complement membrane attackA P Weetman, M Freeman, B P Morgan
Immunology|February 1, 1992
Expression and function of membrane attack complex inhibitory proteins on thyroid follicular cellsN Tandon, B P Morgan, A P Weetman
The Biochemical Journal|April 15, 1990
Reversible cell damage by T-cell perforins. Calcium influx and propidium iodide uptake into K562 cells in the absence of lysisJ Jones, M B Hallett, B P Morgan
Biochemical Society Transactions|July 26, 2000
Non-lethal effects of perforin on polymorphonuclear leukocytesJ I Hopkins, J Jones, B P Morgan
Journal of Immunological Methods|June 5, 1999
Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cellsO B Spiller, C L Harris, B P Morgan
Biochemical Society Transactions|July 18, 2000
Therapeutic uses of recombinant complement receptorsB P Morgan, N K Rushmere, C L Harris
Pageof 25